biohaven: "rimegepant pivotal phase 3 trial results -- conference call.".
gelfand noted the impact on hdl may be balanced by the improvement seen in markers of.
shocking figures uncovered by labour show some patients are suffering agonising waits of as many as 541 days to begin treatment.